View Older Stories View More Recent Stories

Feb 17, 2026 03:36AM Baird Starts Tempus AI Inc (TEM) at Outperform
Jan 27, 2026 08:33AM Tempus AI test outperforms standard biomarkers in predicting immunotherapy
Jan 21, 2026 08:30AM Tempus launches AI-powered biomarker prediction tool Paige Predict
Jan 12, 2026 07:00AM Northwestern Medicine partners with Tempus to expand cancer genomic testing
Jan 12, 2026 05:13AM Tempus AI (TEM) call put ratio 1.1 calls to 1 put into updated guidance
Jan 12, 2026 04:07AM Tempus AI reports preliminary 2025 revenue of $1.27 billion, up 83%
Jan 12, 2026 04:07AM Tempus AI reports record contract value exceeding $1.1 billion
Jan 8, 2026 08:32AM Tempus presents eight research abstracts at ASCO GI symposium
Dec 8, 2025 05:30AM TD Cowen Reiterates Hold Rating on Tempus AI Inc (TEM)
Nov 25, 2025 06:14AM Tempus AI Inc (TEM) PT Raised to $105 at BTIG
Nov 14, 2025 08:31AM Tempus partners with IFLI on follicular lymphoma research study
Nov 5, 2025 01:52AM Tempus AI Inc (TEM) PT Lowered to $95 at Canaccord Genuity
Nov 4, 2025 04:57PM Tempus AI, Inc (TEM) Reports Q3 Loss of $0.11, Offers Guidance
Nov 4, 2025 10:50AM Tempus AI (TEM) call put ratio 2.9 calls to 1 put into quarter results
Nov 3, 2025 11:00AM Tempus AI (TEM) call put ratio 1.4 calls to 1 put into quarter results
Oct 21, 2025 09:21AM Tempus AI valuation catches up with its growth, says TD Cowen downgrading stock
Oct 21, 2025 05:26AM TD Cowen Downgrades Tempus AI Inc (TEM) to Hold
Oct 20, 2025 05:11AM Canaccord Genuity Reiterates Buy Rating on Tempus AI Inc (TEM)
Oct 16, 2025 08:32AM Tempus partners with Whitehawk Therapeutics for cancer research
Oct 1, 2025 12:24PM Ambry Genetics enhances breast cancer risk assessment tool with breast density
Sep 26, 2025 07:16AM Tempus AI Inc (TEM) PT Raised to $95 at Guggenheim
Sep 15, 2025 08:01AM Renalytix partners with Tempus AI to expand kidney disease testing
Sep 12, 2025 06:44AM Tempus AI Inc (TEM) PT Raised to $98 at H.C. Wainwright
Sep 11, 2025 08:30AM Tempus receives FDA clearance for updated cardiac imaging device
Sep 10, 2025 12:37PM Stifel on Tempus AI Inc (TEM): 'we struggle to find upside to the current valuation'
Sep 2, 2025 06:53AM H.C. Wainwright Starts Tempus AI Inc (TEM) at Buy
Aug 22, 2025 09:20AM Tempus acquires digital pathology AI company Paige for $81.25 million
Aug 20, 2025 05:33AM Tempus AI Inc (TEM) PT Raised to $85 at BTIG
Aug 18, 2025 04:10PM Tempus AI director files to sell $3.1 million in stock
Aug 13, 2025 10:27AM Tempus AI Inc (TEM) PT Raised to $72 at TD Cowen
Aug 8, 2025 06:53AM Tempus AI (TEM) Files Mixed Shelf
Aug 8, 2025 06:18AM Tempus AI, Inc (TEM) Tops Q2 EPS by 3c
Aug 8, 2025 06:03AM Tempus AI, Inc (TEM) Reports Q2 Loss of $0.22, provides guidance
Aug 8, 2025 05:29AM Tempus AI (TEM) call put ratio 1.6 calls to 1 put into quarter results
Aug 7, 2025 11:37AM Tempus AI (TEM) call put ratio 2.1 calls to 1 put into quarter results
Aug 7, 2025 05:38AM Tempus AI (TEM) call put ratio 1.8 calls to 1 put quarter results
Jul 18, 2025 04:00PM TEM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Tempus AI, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Jul 16, 2025 08:00AM Tempus receives FDA clearance for heart condition detection software
Jul 13, 2025 04:00PM TEM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Tempus AI, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Jul 13, 2025 11:14AM TEM INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Tempus AI, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
Jul 9, 2025 04:00PM Personalis extends Tempus partnership to include colorectal cancer testing
Jul 8, 2025 08:34AM Tempus AI expands care pathway platform to breast cancer
Jul 7, 2025 05:15PM TEM INVESTOR NOTICE: Tempus AI, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Jul 7, 2025 04:00PM TEM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Tempus AI, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Jul 1, 2025 04:00PM TEM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Tempus AI, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Jun 30, 2025 11:25AM INVESTOR DEADLINE: Tempus AI, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - TEM
Jun 30, 2025 07:00AM Tempus AI (TEM) Announces Proposed $400M Convertible Senior Notes Offering to Optimize Capital Structure and Reduce Interest Expense
Jun 25, 2025 04:00PM TEM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Tempus AI, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Jun 24, 2025 04:05PM INVESTOR ALERT: Tempus AI, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - TEM
Jun 19, 2025 04:00PM TEM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Tempus AI, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
View More Recent Stories View Older Stories